Enumeral Biomedical Holdings, Inc.: 10-Q filed 2014-03-13

Name: Enumeral Biomedical Holdings, Inc.: 10-Q filed 2014-03-13
Creator: Enumeral Biomedical Holdings, Inc.

What Enumeral Biomedical Holdings, Inc. reported in its quarterly report filed 2014-03-13 (fiscal Q1 2014): 18 published measures, 46 facts as tagged in accession 0001561551-14-000004.

This filing

Form: 10-Q (quarterly report)
Filed: 2014-03-13
Fiscal period: fiscal Q1 2014
Accession: 0001561551-14-000004 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Enumeral Biomedical Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2014-01-31	4,788	USD
At 2013-10-31	23,728	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2014-01-31	16,705	USD
At 2013-10-31	14,617	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2014-01-31	962	USD
At 2013-10-31	17,902	USD
At 2013-01-31	1,408	USD
At 2012-10-31	5,084	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	-21,028	USD	92
2012-02-27 to 2014-01-31	-40,717	USD	705
2012-11-01 to 2013-01-31	-10,376	USD	92

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	-18,940	USD	92
2012-02-27 to 2014-01-31	-42,455	USD	705
2012-11-01 to 2013-01-31	-6,676	USD	92

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	2,000	USD	92
2012-02-27 to 2014-01-31	43,417	USD	705
2012-11-01 to 2013-01-31	3,000	USD	92

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2014-01-31	-40,717	USD
At 2013-10-31	-19,689	USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	6,190,000	shares	92
2012-11-01 to 2013-01-31	5,000,000	shares	92

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

Period	Unit	Days
2013-11-01 to 2014-01-31	USD/shares	92
2012-02-27 to 2014-01-31	USD/shares	705
2012-11-01 to 2013-01-31	USD/shares	92

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	-21,028	USD	92
2012-02-27 to 2014-01-31	-40,717	USD	705
2012-11-01 to 2013-01-31	-10,376	USD	92

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2014-01-31	4,788	USD
At 2013-10-31	23,728	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2014-01-31	2,088	USD
At 2013-10-31	2,000	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	21,028	USD	92
2012-02-27 to 2014-01-31	40,717	USD	705
2012-11-01 to 2013-01-31	10,376	USD	92

Total equity including noncontrolling interests

Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.

Period	Value	Unit	Days
At 2014-01-31	-11,917	USD
At 2013-10-31	9,111	USD

Profit or loss including noncontrolling interests

Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	-21,028	USD	92
2012-02-27 to 2014-01-31	-40,717	USD	705
2012-11-01 to 2013-01-31	-10,376	USD	92

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	21,028	USD	92
2012-02-27 to 2014-01-31	40,717	USD	705
2012-11-01 to 2013-01-31	10,376	USD	92

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2012-02-27 to 2014-01-31	28,800	USD	705

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2013-11-01 to 2014-01-31	88	USD	92
2012-02-27 to 2014-01-31	2,088	USD	705
2012-11-01 to 2013-01-31	3,700	USD	92

Inspect the source

Entity: Enumeral Biomedical Holdings, Inc. / CIK 0001561551
Captured: 2026-09-22 19:52 UTC
SEC response SHA-256: 6114205c55b99bc1ed9e32f69ccda777fafa1416a587c9f9d51a573f8a356bc0

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001561551.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))